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Abstract
The alkylamines and their related boron derivatives demonstrated potent
cytotoxicity against the growth of murine and human tissue cultured
cells. These agents did not necessarily require the boron atom to
possess potent cytotoxic action in certain tumor lines. Their ability
to suppress tumor cell growth was based on their inhibition of DNA and
protein syntheses. DNA synthesis was reduced because purine synthesis
was blocked at the enzyme site of IMP dehydrogenase by the agents. In
addition ribonucleotide reductase and nucleoside kinase activities were
reduced by the agents which would account for the reduced d[NTP] pools.
The DNA template or molecule may be a target of the drugs with regard to
binding of the drug to nucleoside bases or intercalaction of the drug
between DNA base pairs. Only some of the agents caused DNA
fragmentation with reduced DNA viscosity. These effects would
contribute to overall cell death afforded by the agents.
Introduction
Alkylamines and their borane derivatives have shown potent hypolipidemic
activity in mice, reducing LDL cholesterol and serum cholesterol and
triglyceride levels while elevating HDL cholesterol levels[l,2]. The
long chain derivatives, e.g.N.N-dimethyloctadecylamine borane, afforded
the most potent hypolipidemic activity [2]. A positive correlation
between hypolipidemic activity and cytotoxicity has previously been
demonstrated for a number of boron containing compounds including amino
acids, amides, esters, and peptides [3-7]. Thus, the purpose of this
study is to determine if this correlation exists for a series of
alkylamines and their borane derivatives. Antineoplastic and cytotoxic
activity will be determined against murine L-1210 lymphoid leukemia,
human Tmolt3 leukemia, HeLa-S
3 uterine carcinoma, A549 lung, colorectal
adenocarcinoma, KB nasopharynx, osteosarcoma, and glioma. The mode of
action of four representative compounds in the series will be
investigated for their effects on L-1210 lymphoid leukemia cell nucleic
acid metabolism.
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Materials and ethods
Source of Compounds
All of the alkylamines and their boron derivatives have been synthesized
previously[2] All chemical and physical characteristic of the compounds
were identical to those reported [1,2]. All other chemicals, substrates
and co-factors were obtained from Sigma Chemical Co. Isotopes were
purchased from New England Nuclear [DuPont]
Antineoplastic Activity
Compounds 1-22 were tested for i.n V.$vo anti-neoplastic activity in the
Ehrlich ascites carcinoma screen in CFI male mice (-28g) at 8 mg/kg/day,
I.P. Drugs were administered for nine days. The tumor was then harvested
and the volume and astrocrit were determined in order to calculate the
percent inhibition of tumor growth on day I0. 6-Meracaptopurine was used
as the internal standard. [5]
Cytotoxic Activity
Compound 1-22 were tested for cytotoxic activity by preparing 1 mM
solutions of each drug in 0.05% Tween 80/Hz0 by homogenization. The
solutions were sterilized by passing them through an Acrodisc filter
(45). The following cell lines were maintained by the literature
techniques 4 for murine L-12i0 lymphoid leukemia, rat UMR-106
osteosarcoma, human Tmolt3 acute lymphoblastic T-cell leukemia,
colorectal adenocarcinoma SW480, lung A549, osteosarcoma TE418, KB
epidermoid nasopharynx and HeLa-S
3 suspended cervical carcinoma. The
protocl of Geran et al. [8] was used to assess cytotoxicity by the
trypan blue exclusion for the suspended tumor cells. Solid tumor
cytotoxicity was determined by the method of Leibovvitz et al. [9] using
0.2% crystal violet/20% MeOH staining and evaluation at 580 nm in a
microplate reader. Standards were determined in each cell line. The
compound’s ED-50 values, i.e. the concentration which inhibited 50%
growth, was expressed in g/ml.
Incorporation Studies
Incorporation of labeled precursors into 3H-DNA, 3H-RNA and 3H-protein
into 106 L-1210 cells was determined by the method of Liao et al. [i0].
The concentration response of compounds 4, 12, 14 and 22 for inhibition
of DNA, RNA and protein syntheses was determined after 60 min at 25, 50
and i00 M. 1-14C-Glycine (53.0 mCi/mol) incorporation into purines was
determined by the method of Cadman et al. [ii]. 14C-Formate (53.0
mCi/mol) incorporation into pyrimidines was determined by the method of
Christopherson et al.[12].
Enzyme Assays
Inhibition of various enzyme activities was carried out by first
preparing the appropriate L-1210 cell homogenate or subcellular
fraction, then adding the test drug during the enzyme assay. For the
concentration response studies, inhibition of enzyme activity was
determined at 25, 50 and i00 M after incubation for 60 min. DNA
polymerase activity was determined in a cytoplasmic extract isolated
by the method of Eichler et al. [13]. The polymerase assay was that of
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Sawada et al. [14], with (3H)-TTP. Messenger-, ribosomal- and transfer-
RNA polymerase enzymes were isolated with different concentrations of
ammonium sulfate (Anderson et al., [15] Hall et al. [16] and the
individual RNA polymerase activities were determined using 3H-UTP.
Ribonucleoside reductase activity was measured with 14C-CDP [17]. The
deoxyribonucleotides labeled with 14C-dCDP were separated from 14C-rCDP
from the ribonucleotides by TLC on PEI plates. Thymidine, TMP and TDP
kinase activities were measured with 3H-thymidine (58.3 mCi/mol) in the
medium of Maley and Ochoa [18]. PRPP amidotransferase activity was
determined by the method of Spassova et al. [19], and IMP dehydrogenase
activity was determined with 14C-IMP (Amersham, Arlington Heights, IL)
where XMP was separated on PEI plates (Fisher Scientific) by TLC (Becker
et al.[20]). Carbamyl phosphate synthetase activity was determined by
the method of Kalman et al. 21 and citrulline was determined
colorimetrically (Archibald, [22]). Aspartate transcarbamylase activity
was determined by the method of Kalman et al. [21] and carbamyl aspartate
was determined colorimetrically [23]. Thymidylate synthetase activity
was analyzed by the method of Kampf et al. [24]. The 3H20 measured was
proportional to the amount of TMP formed from (3H)-dUMP. Dihydrofolate
reductase activity was determined by the spectrophotometric method of Ho
et ai.[25]. Protein was determined for all of the enzymatic assays
(Lowry et al. [26]).
DNA Assays
Deoxyribonucleoside triphosphates were extracted by the method of
Bagnara and Finch [27]. Deoxyribonucleoside triphosphates were
determined by the method of Hunting and Henderson [28] with calf thymus
DNA, E. coli DNA polymerase I, non-limiting amounts of the three
deoxyribonucleoside triphosphates not being assayed, and either 0.4 mCi
of (3H-methyl)-dTTP or (5-3H)-dCTP.
The effects of the compounds on DNA strand scission were determined by
the methods of Suzuki et al. [29], Pera et al.[30], and Woynarowski et
al. [31]. L-1210 lymphoid leukemia cells were incubated with i0 Ci
thymidine methyl-3H, 84.0 Ci/mmol and drug at i00 M for 24 h at 37C.
After harvesting the LI210 cells (107), the cells were centrifuged at
600 g x i0 min in PBS, washed and suspended in 1 ml of PBS. Lysis
buffer (0.5 ml; 0.5 M NaOH, 0.02 M EDTA, 0.01% Triton X-100 and 2.5%
sucrose) was layered onto a 5-20% alkaline-sucrose gradient (5 ml; 0.3 M
NaOH, 0.7 KCI and 0.01 M EDTA) followed by 0.2 ml cell preparation.
After incubating 2.5 hr at room temperature, the gradient was
centrifuged at 12,000 rpm at 20C for 60 min (Beckman rotor SW60).
Fractions (0.2 ml) were collected from the top of the gradient,
neutralized with 0.2 ml of 0.3 N HCI, and radioactivity measured.
Thermal calf thymus DNA [ct-DNA] denaturation studies, UV absorption
studies and DNA viscosity studies were conducted after incubating
compounds 4, 12, 14 and 22 at i00 M in PBS buffer pH 7.2 at 37oC for 24
hr[32].
RESULTS
A number of compounds were active in the Ehrlich ascites carcinoma
screen compound 4 afforded 77% inhibition, compound 5 caused 86%
inhibition and compound 11 caused 87% while compound 14 resulted in 76%
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inhibition of tumor growth in vivo. Generally the alkylamine amines
were not as potent as the boron derivatives. [Table i].
Table I. Structures and .I.n. Vivo.. Anti-neoplastic Activity of Alkylamine
and Their Boron Derivatives at 8 mg/Kg/day, I.P.
Compound # Name Percent Inhibition
N 6 Ehrlich Ascites Carcinoma Growth
1 N,N-Dimethylbenzylamine Borane 67
2 N,N-Dimethyl-n-butylamine Borane 59
3 N,N-Dimethyl-n-hexylamine Butane 69
4 N,N-Dimethyl-n-octylamine Borane 77
5 N,N-Dimethyl-n-decylamine Borane 86
6 N,N-Dimethyl-n-undecylamin Butane 67
7 N,N-Dimethyl-n-dodecylamin Borane 58
8 N,N-Dimethyl-n-tridecylamin Borane 34
9 N,N-Dimethyl-n-tetradecylamine Borane 54
i0 N,N-Dimethyl-n-pentadecylamine Borane 66
ii N,N-Dimethyl-n-hexadecylamine Butane 87
12 N,N-Dimethyl-n-octadecylamine Borane 52
13 N,N-Dimethyl-n-octadecylamine 43
14 N-Methyl-n-octadecylamine 76
15 Decylamine 37
16 Undecylamine 37
17 Dodecylamine 48
18 Tridecylamine 38
19 Tetradecylamine 56
20 Hexadecylamine 44
21 Didecylamine 45
22 Octadecylamine 35
6MP 99
’n vitro ’cyctoxicity demonstrated that a number of the compounds
afforded ED-50 values less than 2 g/ml. In the L-1210 lymphoid leukemia
screen compounds I, 2, 7, 8, 9, 10, 13, 16, and 18 were active. In the
human Tmolt3 leukemia screen, compounds 4, 6, 7, 8, 13, 14, 15, 17, 18,
19, 21 and 22 were effective. The HeLa-S
3 uterine carcinoma growth was
reduced by compounds I, 3, 4, , 6, 8, I0, II and 16. KB nasopharynx
growth was suppressed by compounds 14, 19 and 21. SW-480 colon
adenocarcinoma growth was reduced by compounds 11, 12, 14, 16, 19, 20
and 21. Lung A549 growth was reduced by 7, 14, 18, 19, 21 and 22. Bone
osteosarcoma growth was reduced by compounds 7, 9, 14, 17, 18, 19, 21
and 22. Brain glioma growth was suppressed by compounds 7, 9, 11, 14,
17, 18, 19, 21 and 22.[Table 2]
The mode of action study with four of the derivatives in L-1210 cells
after 60 min incubation showed that DNA synthesis was inhibited 74% at
i00 M for compound 4 whereas compounds 12, 14 and 22 caused 24-54%
reduction. RNA synthesis was only inhibited by compound 4 by 50% and
compound 22 by 16%. RNA synthesis was elevated by compound 12 by 32%
and by compound 14 by 79%. Protein synthesis was reduced 31% to 60%
after 60 min. incubation with the agents. [Table 3-6]
DNA polymerase activity was stimulated by compounds 4 and 12 by 52%
and 106%, respectively but was inhibited 67% and 53% by compounds 14 and
22. mRNA polymerase activity was suppressed 18% to 23% by the compounds.
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rRNA polymerase activity was inhibited by all four compounds 10% to 34%.
t-RNA polymerase activity was suppressed 2% to 28% after 60 min.
incubation. Ribonucleoside reductase activity was suppressed 22% to 34%
at i00 M of the agents. Dihydrofolate reductase activity was reduced
16% by compound 4 but the activity was elevated 31%-48% by compounds 14
and 12. De novo synthesis of purine was inhibited approximately 37% to
57% by the four agents at i00 M after 60 rain incubation. However, the
activity of the regulatory enzyme PRPP amido-transferase activity was
Table 2 Cytotoxicity of Alkylamines and N,N-Dimethylalkylamine Boranes
in Murine and Human Tissue Culture Cell Lines
N=4 ED-50 values g/ml
L-1210 Tmolt3 HeLa-S KB SW480 A549 Bone Brain
Cp’ d Leuk- Leuk- Uterine Naso Colon Lung Osteo- Glioma
emia emia pharynx Sarcoma
#
1 I. 69 2.00 I. 53 3.48 7.52 8.04 5.73 7.71
2 I. 19 2.89 2.18 7.38 2.33 6.85 5.61 6.63
3 3.77 3.90 I. 44 6.84 4.42 6.14 6.66 7.42
4 2.57 1.96 1.62 5.67 5.82 3.76 5.14 7.72
5 3.86 4.85 I. 36 6.72 3.97 5.97 5.44 7.21
6 3.57 1.35 1.78 4.26 6.35 4.87 3.10 4.90
7 1.47 1.35 2.21 6.07 7.27 1.22 1.50 0.63
8 1.47 1.94 1.53 4.39 7.52 7.86 3.75 6.53
9 1.43 2.29 2.29 4.06 7.56 7.69 1.78 1.79
I0 0.95 3.11 1.87 3.61 7.27 7.83 3.28 7.72
II 2.30 2.09 I. 57 5.53 I. 62 2.52 2.38 I. 58
12 2.57 2.06 2.31 3.70 I. 68 4.89 3.75 2.78
13 I. 83 I. 71 2.63 6. II 3.63 6.25 4.32 8.32
14 3.12 1.43 2.89 1.27 1.31 1.15 1.09 0.27
15 3.59 1.74 2.21 3.76 7.52 3.97 4.91
16 1.56 2.43 1.87 4.13 1.56 6.70 3.51 6.73
17 2.48 I. 43 2.47 2.93 5.09 2. I0 I. 84 i. 72
18 I. 47 I. 47 2.29 2.05 4.07 I. 06 I. 98 I. 15
19 2.57 0.97 2.73 1.95 1.31 0.995 1.54 1.13
20 2.68 3.54 2.68 4.16 1.25 4.07 5.66 5.49
21 2.39 0.775 3.14 1.58 1.16 1.06 1.59 1.47
22 2.75 1.87 2.12 3.25 4.03 1.01 1.05 0.84
5FU 1.41 2.14 2.47 1.25 3.09 5.64 1.28
AraC 2.76 2.67 2.13 2.84 3.42 4.60 i. 88
HU* 2.67 3.18 1.96 5.29 4.74 7.37 7.32 2.27
* Hydroxyurea
not significantly affected by the agents with only 15% to 21%
inhibition. Nevertheless, IMP dehydrogenase activity was markedly
reduced by all four agents 38% to 75%. The first enzyme in the
pyrmidine pathway were significantly reduced, i.e. carbamyl phosphate
synthetase activity, which was suppressed 87% by compound 22 whereas the
other three compounds caused 15% to 24% reduction in activity.
Aspartate transcarbamylase activity was reduced 17% by compound 4 and
was elevated by compounds 14 and 22. However, thymidylate synthtase
activity was unaffected by the agents. Thymidine kinase activity was
reduced 46% to 69%, TMP kinase activity was reduced 21% to 37% and TTP
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kinase activity was reduced 10% to 35% by the four agents at I00 M.
d[NTP] pools were reduced by the derivatives after 60 rain. incubation.
d[ATP] levels were reduced 16% to 21%. d[GTP] levels were reduced
Table 3 Effects of N,N-Dimethyl--octylamine Borane (4) on L-1210
Leukemia Cell Metabolism over 60 Min
N 6 Percent of Control (X + SD)
Assay Control 25 M 50 M 100M
DNA synthesis
RNA synthesis
Protein synthesis
DNA polymerase alpha
mRNA polymerase
rRNA polymerase
tRNA polymerase
Ribonucleoside reductase
Dihydrofolate reductase
Purine de novo synthesis
PRPP amido transferase
IMP dehydrogenase
100+/-5a
100+/-6b
i00+5c
100+/-6d
100+/-7e
100+/-4f
100+/-7g
100+/-5h
i00+/-5i
00+/-sj
100+/-6k
100+/-51
Carbamyl phosphate synthetase 100+/-7m
Aspartate transcarboxylase 100+/-6n
Thymidylate synthetase 100+/-5o
Thymidine kinase 100+/-6p
Thymidine monophosphat kinase 100+/-7q
Thymidine diphosphate kinase 100+/-6r
d(ATP) 100+/-5s
d(GTP) 100+/-6t
d(CTP) 100+/-5u
d(TTP) 100+/-4v
534" 42+/-2* 262,
103+7 62+6* 50+3*
119+/-5 76+/-4* 694-
73+/-6 141+/-7" 152+/-6"
112+/-7 81+/-5 81+/-4,
149+/-5 118+/-5 90+/-4
91+/-6 89+/-5 77+/-5*
87+5 75+5* 69+4*
94+/-6 86+/-5 84+/-6
95+/-5 64+/-4* 63+/-4*
90+6 80+4* 79+5*
89+/-6 785" 493-
92+/-6 89+/-6 85+/-5
101Z7 99Z6 836
107+/-7 107+/-6 103+/-5
79+/-6* 35+/-4* 354-
72Z5" 63+/-5* 63+/-5*
117+/-7 83+/-6 77+/-5*
84+5
78+4*
48+3*
110+5
Control values for 106 cells/hr
a 7719 dpm; b 1014 dpm, c 17492 dpm, d 9019 dpm, e 1343 dpm, f
325 dpm, g 400 dpm, h 48780 dpm, i 0.144 D O.D. units, j 28624
dpm, k 0.0878 O.D. units, 1 19575 dpm, m 0.807 mol N-carbamyl
aspartate, n 0.273 mmol citrulline, o 77616 dpm, p 1371 dpm, q
1179 dpm, r 1891 dpm, s 17.07 pmoles, t 13.58 pmoles, u 33.60
pmoles, v 31.04 pmoles. * P 0.001 Student’s "t" test
22% to 30%. d[OTP] levels were reduced 32% to 52% whereas d[TTP] levels
were slightly elevated from 105 to 21%.
ct-DNA studies demonstrated that U.V. absorption from 220 nm to 340 nm
was decreased with compounds 4, 14 and 22 and thermal denaturation Tm
values were affected by the presence of the agents after 24 hr. at i00
M; the control Tm value was 85.3 C, compound 4 was 77C, compounds 12
and 22 were 70C, compound 14 was 65C. L-1210 DNA strand scission
studies demonstrated that compounds 12 and 22 after 24 hr. at i00 M
caused essentially no DNA strand scission while compounds 4 and 14 did
cause DNA fragmentation [Fig. I]. ct-DNA viscosity studies demonstrated
that the control value was 324 sec. Whereas after incubating with
compounds 4, 14 and 22, the viscosity time had decreased to 302-318 sec.
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Table 4 Effects of N,N-Dimethyl--octadecylamine Borane(12) on L-1210
Leukemia Cell Metabolism over 60 Min
N 6 Percent of Control
Assay ControI 25M 50M 100M
DNA synthesis
RNA synthesis
Protein synthesis
DNA polymerase alpha
mRNA polymerase
rRNA polymerase
tRNA polymerase
Ribonucleoside reuctase
Dihydrofolate reductase
Purine de novo synthesis
PRPP amido transferase
IMP dehydrogenase
100+/-5
100+/-6
100+/-5
100+/-6
100+/-7
100+/-4
100+/-7
100+/-5
100+/-5
100+/-5
100+/-6
100+/-5
Carbamyl phosphate synthetase 100+7
Aspartate transcarboxylase 100+/-6
Thymidylate synthetase 100+/-5
Tymidine kinase 100+/-6
Thymidine monophosphate kinase 100+/-7
Thymidine diphosphate kinase 100+/-6
d[ATP] 100+/-5
d[GTP] i006
d[CTP] I005
d[TTP] i004
805 50+/-4* 494-
114+/-6 106+/-5 132+/-7-
634- 56+/-5* 484,
157+/-5" 2027- 2066-
74+/-5* 72+/-4* 71+/-5"
805 79+/-4* 694.
966 776- 726-
975 96+/-6 785-
96+/-6 135+/-6- 148+/-7-
605- 624- 543-
85+/-6 79+/-5* 78+/-6*
454- 314- 253-
105+/-6 100+/-7 83+/-5
108+/-6 106+/-5 102+/-6
108+/-6 102+/-5 94+/-5
78+/-5* 76+/-5* 31+/-4-
81+/-6 74+/-6* 73+/-5*
99+/-7 81+/-4 77+/-5*
80+4*
74+/-3*
634-
113+6
Discussion
The alkylamines and their boron derivatives were not as potent as other
boronated amines, heterocyclic amine, peptides or nucleosides, but a few
derivatives at 8 mg/kg/day did produce greater than 80% inhibition of i__n
vivo tumor growth. The majority of the agents were cytotoxic in the
3 suspended cell growth, i.e. L-1210, Tmolt3 and HeLa-S Selected
derivatives demonstrated potent activity in the solid tumor cells
cultures. The alkylamines which contain no boron moiety generally were
more effective against the growth of the solid tumor cell cultures.
This activity may be due to some type of deteregent activity of these
agents being that they are long chain alkyl groups. Furthermore,
compound 14, N-methyl-n-octadecylamine demonstrated the widest activity
against the growth of human cultured tumors cell lines.
The mode of action study demonstrated that L-1210 leukemic cell DNA and
protein syntheses were inhibited from 25 to 100 M within 60 min. The
major effect of the agents appeared to be on de novo purine synthesis
with the regulator enzyme site IMP dehydrogenase being blocked by the
agents. The magnitude of reduction of IMP dehydrogenase
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Table 5 Effects of N-methyl-n-octadecylamine(14) on L-1210 Leukemia. Cell
Metabolism over 60 Min
N 6 Percent of Control
Assay Control 25M 50M 100M
DNA synthesis
RNA synthesis
Protein synthesis
DNA polymerase alpha
mRNA polymerase
rRNA polymerase
tRNA polymerase
Ribonucleoside reductase
Dihydrofolate reductase
Purine de novo synthesis
PRPP amido transferae
IMP dehydrogenase
100+/-5
100+/-6
100+5
100+/-6
100+/-7
100+/-4
100+/-7
100+/-5
100+/-5
100+/-5
100+/-6
100+/-5
Carbamyl phosphate synthetase 100+/-7
Aspartate transcarboxylase 100+/-6
Thymidylate synthetase 100+/-5
Tymidine kinase 100+/-6
Thymidine monophosphate kinase 100+/-7
Thymidine diphosphate kinase 100+/-6
d[ATP] 100+5
d[GTP] i006
d[CTP] 100+/-5
d{TTP] i004
765, 69+/-5* 76+/-4*
1556- 176+/-5- 17g6"
74+/-4 62+/-5 51+/-5"
100+/-5 53+/-4 33+/-3*
96+6 83+6 77+5*
78+/-5* 75+/-5* 68+/-5*
103+/-7 86+/-7 82+/-6
104+/-6 79+/-6 68+/-5*
107+/-7 131+/-6 131+/-5
57+/-5* 47+/-5* 434-
87+6 87+5 82+6
75+/-5* 60+5* 45+/-4*
81+/-6 76+/-5* 76+/-4*
119+/-7 139+7" 122+/-6
103+5 108+6 98+6
68+6 44+/-5* 38+/-4*
80+/-7 71+/-5- 694"
866 726, 65+/-5*
824
70+5*
61+/-5"
115+/-6.
activity was of sufficient amount to explain the observed reduction of
purine synthesis as well as DNA synthesis. Other metabolic site which
were affected marginally by the agents were m-, r-and t-RNA polymerases,
ribonucleoside reductase, carbamyl phosphate synthetase, and nucleoside
kinases. The inhibition of the activities of these enzymes would be
additive with regard to inhibiting DNA synthesis and tumor cell death.
The reduction in some of the d[NTP] pools would also lower DNA
synthesis. The reduction in these pools probably is due to the
inhibition of purine and pyrimidine de novo synthetic pathways for
deoxytriphosphate nucleosides as well as ribonucleoside reductase
activity for the conversion of ribosenucleotides to
deoxyribonucleotides, ct-DNA studies with the agents suggest that there
was some type of interaction with the nucleosides of DNA as demonstrated
by the decrease in U.V. absorption, decreased Tm values and lower DNA
viscosity. In the L-1210 cells the observed DNA fragmentation would
cause cell death and explain the reduction in DNA viscosity.
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Table 6 Effects of Octadecylamine(22) on L-1210 Leukemia Cell Metabolism
over 60 Min
N 6 Percent of Control
Assay Control 25M 50M 100M
DNA synthesis
RNA synthesis
Protein synthesis
DNA polymerase
mRNA polymerase
rRNA polymerase
tRNA polymerase
Ribonucleoside reductase
Dihydrofolate reductase
Purine synthesis
PRPP amido transferase
IMP dehydrogenase
1005
100+/-6
100+/-5
100+6
100+/-7
100+/-4
100+/-7
100+/-5
100+/-5
100+/-5
100+/-6
100+/-5
Carbamyl phosphate synthetase 100+/-7
Aspartate transcarboxylase 100+/-6
Thymidylate synthetase 100+/-5
Thymidine kinase 100+/-6
Thymidine monophosphat kinase 100+/-7
Thymidine diphosphate kinase 100+/-6
d[ATP] I005
d[GTP] i006
d[CTP] 100+/-5
d[TTP] I004
90+/-6 73+/-5* 46+/-5*
i186 i157 84+/-5
86+/-6 85+/-5 40+/-4*
94+5 81+6 47+5*
89+6 83+6 82+6
995 83+/-6 66+5*
103+/-6 102+6 98+/-5
130+6 84+5 66+4*
119+/-7 116+/-6 96+/-5
70+/-4* 545- 515,
94+5 86+6 85+6
194+/-7 119+/-6 62+/-5*
71+/-5- 31+/-4- 13+/-3-
123+5 159+6" 164+6-
105+/-6 110+/-6 104+/-6
91+5 74+5* 54+5*
926 765- 705-
105+/-7 101+/-6 90+/-5
795-
76+4*
68+/-4*
115+6
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